 | • レポートコード：MRC2-11QY11353 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は胆管炎のグローバル市場について調査・分析したレポートです。種類別（急性胆管炎、原発性硬化性胆管炎、続発性硬化性胆管炎、再発性化膿性胆管炎）市場規模、用途別（臨床実習、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別胆管炎の競争状況、市場シェア ・世界の胆管炎市場：種類別市場規模 2015年-2020年（急性胆管炎、原発性硬化性胆管炎、続発性硬化性胆管炎、再発性化膿性胆管炎） ・世界の胆管炎市場：種類別市場規模予測 2021年-2026年（急性胆管炎、原発性硬化性胆管炎、続発性硬化性胆管炎、再発性化膿性胆管炎） ・世界の胆管炎市場：用途別市場規模 2015年-2020年（臨床実習、その他） ・世界の胆管炎市場：用途別市場規模予測 2021年-2026年（臨床実習、その他） ・北米の胆管炎市場分析：米国、カナダ ・ヨーロッパの胆管炎市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの胆管炎市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の胆管炎市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの胆管炎市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Taiho Pharmaceutical、Mayo Clinic、Bayer、Gilead Sciences、RiemserArzneimittel、Zambon ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cholangitis is an infection of the biliary tract with the potential to cause significant morbidity and mortality.
The key factors contributing to the growth of the cholangitis market are the changing lifestyle, increasing awareness of healthcare and geriatric population increase.
Market Analysis and Insights: Global Cholangitis Market
The global Cholangitis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cholangitis Scope and Market Size
Cholangitis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cholangitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Taiho Pharmaceutical
Mayo Clinic
Bayer
Gilead Sciences
RiemserArzneimittel
Zambon
…
Market segment by Type, the product can be split into
Acute Cholangitis
Primary Sclerosing Cholangitis
Secondary Sclerosing Cholangitis
Recurrent Pyogenic Cholangitis
Market segment by Application, split into
Clinical Practise
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cholangitis Revenue
1.4 Market by Type
1.4.1 Global Cholangitis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Acute Cholangitis
1.4.3 Primary Sclerosing Cholangitis
1.4.4 Secondary Sclerosing Cholangitis
1.4.5 Recurrent Pyogenic Cholangitis
1.5 Market by Application
1.5.1 Global Cholangitis Market Share by Application: 2020 VS 2026
1.5.2 Clinical Practise
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cholangitis Market Perspective (2015-2026)
2.2 Global Cholangitis Growth Trends by Regions
2.2.1 Cholangitis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cholangitis Historic Market Share by Regions (2015-2020)
2.2.3 Cholangitis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cholangitis Market Growth Strategy
2.3.6 Primary Interviews with Key Cholangitis Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cholangitis Players by Market Size
3.1.1 Global Top Cholangitis Players by Revenue (2015-2020)
3.1.2 Global Cholangitis Revenue Market Share by Players (2015-2020)
3.1.3 Global Cholangitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cholangitis Market Concentration Ratio
3.2.1 Global Cholangitis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cholangitis Revenue in 2019
3.3 Cholangitis Key Players Head office and Area Served
3.4 Key Players Cholangitis Product Solution and Service
3.5 Date of Enter into Cholangitis Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cholangitis Historic Market Size by Type (2015-2020)
4.2 Global Cholangitis Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cholangitis Market Size by Application (2015-2020)
5.2 Global Cholangitis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cholangitis Market Size (2015-2020)
6.2 Cholangitis Key Players in North America (2019-2020)
6.3 North America Cholangitis Market Size by Type (2015-2020)
6.4 North America Cholangitis Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cholangitis Market Size (2015-2020)
7.2 Cholangitis Key Players in Europe (2019-2020)
7.3 Europe Cholangitis Market Size by Type (2015-2020)
7.4 Europe Cholangitis Market Size by Application (2015-2020)
8 China
8.1 China Cholangitis Market Size (2015-2020)
8.2 Cholangitis Key Players in China (2019-2020)
8.3 China Cholangitis Market Size by Type (2015-2020)
8.4 China Cholangitis Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cholangitis Market Size (2015-2020)
9.2 Cholangitis Key Players in Japan (2019-2020)
9.3 Japan Cholangitis Market Size by Type (2015-2020)
9.4 Japan Cholangitis Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cholangitis Market Size (2015-2020)
10.2 Cholangitis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cholangitis Market Size by Type (2015-2020)
10.4 Southeast Asia Cholangitis Market Size by Application (2015-2020)
11 India
11.1 India Cholangitis Market Size (2015-2020)
11.2 Cholangitis Key Players in India (2019-2020)
11.3 India Cholangitis Market Size by Type (2015-2020)
11.4 India Cholangitis Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cholangitis Market Size (2015-2020)
12.2 Cholangitis Key Players in Central & South America (2019-2020)
12.3 Central & South America Cholangitis Market Size by Type (2015-2020)
12.4 Central & South America Cholangitis Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Taiho Pharmaceutical
13.1.1 Taiho Pharmaceutical Company Details
13.1.2 Taiho Pharmaceutical Business Overview
13.1.3 Taiho Pharmaceutical Cholangitis Introduction
13.1.4 Taiho Pharmaceutical Revenue in Cholangitis Business (2015-2020))
13.1.5 Taiho Pharmaceutical Recent Development
13.2 Mayo Clinic
13.2.1 Mayo Clinic Company Details
13.2.2 Mayo Clinic Business Overview
13.2.3 Mayo Clinic Cholangitis Introduction
13.2.4 Mayo Clinic Revenue in Cholangitis Business (2015-2020)
13.2.5 Mayo Clinic Recent Development
13.3 Bayer
13.3.1 Bayer Company Details
13.3.2 Bayer Business Overview
13.3.3 Bayer Cholangitis Introduction
13.3.4 Bayer Revenue in Cholangitis Business (2015-2020)
13.3.5 Bayer Recent Development
13.4 Gilead Sciences
13.4.1 Gilead Sciences Company Details
13.4.2 Gilead Sciences Business Overview
13.4.3 Gilead Sciences Cholangitis Introduction
13.4.4 Gilead Sciences Revenue in Cholangitis Business (2015-2020)
13.4.5 Gilead Sciences Recent Development
13.5 RiemserArzneimittel
13.5.1 RiemserArzneimittel Company Details
13.5.2 RiemserArzneimittel Business Overview
13.5.3 RiemserArzneimittel Cholangitis Introduction
13.5.4 RiemserArzneimittel Revenue in Cholangitis Business (2015-2020)
13.5.5 RiemserArzneimittel Recent Development
13.6 Zambon
13.6.1 Zambon Company Details
13.6.2 Zambon Business Overview
13.6.3 Zambon Cholangitis Introduction
13.6.4 Zambon Revenue in Cholangitis Business (2015-2020)
13.6.5 Zambon Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cholangitis Key Market Segments
Table 2. Key Players Covered: Ranking by Cholangitis Revenue
Table 3. Ranking of Global Top Cholangitis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cholangitis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Acute Cholangitis
Table 6. Key Players of Primary Sclerosing Cholangitis
Table 7. Key Players of Secondary Sclerosing Cholangitis
Table 8. Key Players of Recurrent Pyogenic Cholangitis
Table 9. Global Cholangitis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Cholangitis Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Cholangitis Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Cholangitis Market Share by Regions (2015-2020)
Table 13. Global Cholangitis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Cholangitis Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Cholangitis Market Growth Strategy
Table 19. Main Points Interviewed from Key Cholangitis Players
Table 20. Global Cholangitis Revenue by Players (2015-2020) (Million US$)
Table 21. Global Cholangitis Market Share by Players (2015-2020)
Table 22. Global Top Cholangitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholangitis as of 2019)
Table 23. Global Cholangitis by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Cholangitis Product Solution and Service
Table 26. Date of Enter into Cholangitis Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cholangitis Market Size by Type (2015-2020) (Million US$)
Table 29. Global Cholangitis Market Size Share by Type (2015-2020)
Table 30. Global Cholangitis Revenue Market Share by Type (2021-2026)
Table 31. Global Cholangitis Market Size Share by Application (2015-2020)
Table 32. Global Cholangitis Market Size by Application (2015-2020) (Million US$)
Table 33. Global Cholangitis Market Size Share by Application (2021-2026)
Table 34. North America Key Players Cholangitis Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Cholangitis Market Share (2019-2020)
Table 36. North America Cholangitis Market Size by Type (2015-2020) (Million US$)
Table 37. North America Cholangitis Market Share by Type (2015-2020)
Table 38. North America Cholangitis Market Size by Application (2015-2020) (Million US$)
Table 39. North America Cholangitis Market Share by Application (2015-2020)
Table 40. Europe Key Players Cholangitis Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Cholangitis Market Share (2019-2020)
Table 42. Europe Cholangitis Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Cholangitis Market Share by Type (2015-2020)
Table 44. Europe Cholangitis Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Cholangitis Market Share by Application (2015-2020)
Table 46. China Key Players Cholangitis Revenue (2019-2020) (Million US$)
Table 47. China Key Players Cholangitis Market Share (2019-2020)
Table 48. China Cholangitis Market Size by Type (2015-2020) (Million US$)
Table 49. China Cholangitis Market Share by Type (2015-2020)
Table 50. China Cholangitis Market Size by Application (2015-2020) (Million US$)
Table 51. China Cholangitis Market Share by Application (2015-2020)
Table 52. Japan Key Players Cholangitis Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Cholangitis Market Share (2019-2020)
Table 54. Japan Cholangitis Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Cholangitis Market Share by Type (2015-2020)
Table 56. Japan Cholangitis Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Cholangitis Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Cholangitis Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Cholangitis Market Share (2019-2020)
Table 60. Southeast Asia Cholangitis Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Cholangitis Market Share by Type (2015-2020)
Table 62. Southeast Asia Cholangitis Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Cholangitis Market Share by Application (2015-2020)
Table 64. India Key Players Cholangitis Revenue (2019-2020) (Million US$)
Table 65. India Key Players Cholangitis Market Share (2019-2020)
Table 66. India Cholangitis Market Size by Type (2015-2020) (Million US$)
Table 67. India Cholangitis Market Share by Type (2015-2020)
Table 68. India Cholangitis Market Size by Application (2015-2020) (Million US$)
Table 69. India Cholangitis Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Cholangitis Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Cholangitis Market Share (2019-2020)
Table 72. Central & South America Cholangitis Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Cholangitis Market Share by Type (2015-2020)
Table 74. Central & South America Cholangitis Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Cholangitis Market Share by Application (2015-2020)
Table 76. Taiho Pharmaceutical Company Details
Table 77. Taiho Pharmaceutical Business Overview
Table 78. Taiho Pharmaceutical Product
Table 79. Taiho Pharmaceutical Revenue in Cholangitis Business (2015-2020) (Million US$)
Table 80. Taiho Pharmaceutical Recent Development
Table 81. Mayo Clinic Company Details
Table 82. Mayo Clinic Business Overview
Table 83. Mayo Clinic Product
Table 84. Mayo Clinic Revenue in Cholangitis Business (2015-2020) (Million US$)
Table 85. Mayo Clinic Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Product
Table 89. Bayer Revenue in Cholangitis Business (2015-2020) (Million US$)
Table 90. Bayer Recent Development
Table 91. Gilead Sciences Company Details
Table 92. Gilead Sciences Business Overview
Table 93. Gilead Sciences Product
Table 94. Gilead Sciences Revenue in Cholangitis Business (2015-2020) (Million US$)
Table 95. Gilead Sciences Recent Development
Table 96. RiemserArzneimittel Company Details
Table 97. RiemserArzneimittel Business Overview
Table 98. RiemserArzneimittel Product
Table 99. RiemserArzneimittel Revenue in Cholangitis Business (2015-2020) (Million US$)
Table 100. RiemserArzneimittel Recent Development
Table 101. Zambon Company Details
Table 102. Zambon Business Overview
Table 103. Zambon Product
Table 104. Zambon Revenue in Cholangitis Business (2015-2020) (Million US$)
Table 105. Zambon Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cholangitis Market Share by Type: 2020 VS 2026
Figure 2. Acute Cholangitis Features
Figure 3. Primary Sclerosing Cholangitis Features
Figure 4. Secondary Sclerosing Cholangitis Features
Figure 5. Recurrent Pyogenic Cholangitis Features
Figure 6. Global Cholangitis Market Share by Application: 2020 VS 2026
Figure 7. Clinical Practise Case Studies
Figure 8. Others Case Studies
Figure 9. Cholangitis Report Years Considered
Figure 10. Global Cholangitis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Cholangitis Market Share by Regions: 2020 VS 2026
Figure 12. Global Cholangitis Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Cholangitis Market Share by Players in 2019
Figure 15. Global Top Cholangitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholangitis as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Cholangitis Revenue in 2019
Figure 17. North America Cholangitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Cholangitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Cholangitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Cholangitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Cholangitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Cholangitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Cholangitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
多形性膠芽腫（GBM）再発治療の世界市場（～2026年） Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain. The increasing incidence of seizure is expected to drive the recurrent glioblastoma multiforme treatment market. Market Analysis and Insights: Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market…- 急性反復発作の世界市場（～2026年） Based on product, the market is categorized into USL-261, NRL-1, AZ-002, Diastat Rectal Gel {DRG. Market Analysis and Insights: Global Acute Repetitive Seizures Market The global Acute Repetitive Seizures market size is projected to reach US$ 245.3 million by 2026, from US$ 174.4 million in 2020, at…
- 二次性副甲状腺機能亢進症治療の世界市場（～2026年） Secondary hyperparathyroidism refers to the excessive secretion of parathyroid hormone by the parathyroid glands in response to hypocalcemia and associated hyperplasia of the glands. In the treatment of secondary hyperparathyroidism due to chronic kidney disease on dialysis calcimimetics do not appe…
- 急性腎不全治療薬の世界市場（～2026年） Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body. Acute re…
- 急性冠症候群（ACS）の世界市場（～2026年） Acute coronary syndrome (ACS) is a syndrome (set of signs and symptoms) due to decreased blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. The most common symptom is chest pain, often radiating to the left shoulder or angle of the jaw, cru…